Zobrazeno 1 - 10
of 26
pro vyhledávání: '"George B, Rodrigues"'
Autor:
Andrew J. Arifin, MD, Sympascho Young, MD, Glenn S. Bauman, MD, Hatim Fakir, PhD, Belal Ahmad, MD, Joanna M. Laba, MD, George B. Rodrigues, MD, PhD, Eric K. Nguyen, MD, Arjun Sahgal, MD, Timothy K. Nguyen, MD, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101220- (2023)
Purpose: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the proportion of patients treated with conventional radi
Externí odkaz:
https://doaj.org/article/20a6e337d7c143a7b5fc88c830acec0f
Autor:
Richard A. Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Joel Bierer, David A. Palma, Dalilah Fortin, Richard I. Inculet, Eric Fréchette, Jacques Raphael, Stewart Gaede, Sara Kuruvilla, Jawaid Younus, Mark D. Vincent, George B. Rodrigues
Publikováno v:
Thoracic Cancer, Vol 13, Iss 13, Pp 1898-1915 (2022)
Abstract Background We compared the health‐related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I‐III esophageal cancer. Methods A total of 96 patients were randomized to standard neoadjuvant cisplatin a
Externí odkaz:
https://doaj.org/article/3b12890c920c426ab850df2b1fe0356a
Autor:
Edward Yu, Alison L. Allan, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Lori E. Lowes, David A. Palma, Jacques Raphael, Mark D. Vincent, George B. Rodrigues, Dalilah Fortin, Richard I. Inculet, Eric Frechette, Joel Bierer, Jeffery Law, Jawaid Younus, Richard A. Malthaner
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. Methods We prospectively collected CTC data from pat
Externí odkaz:
https://doaj.org/article/8cb2db1ff05644bd83701d5be8c74a0a
Autor:
Andrew J. Arifin, MD, Vivian S. Tan, MD, Michael Yan, MD, Andrew Warner, MSc, R.G. Boldt, MLIS, Hanbo Chen, MD, George B. Rodrigues, MD, PhD, David A. Palma, MD, PhD, Alexander V. Louie, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101178- (2023)
Purpose: Although the frequency of noninferiority trials is increasing, the consistency of the reporting of these trials can vary. The aim of this systematic review was to assess the reporting quality of radiation therapy noninferiority trials. Metho
Externí odkaz:
https://doaj.org/article/4b053e0acbbc43a082221b7278b47311
Autor:
Dae-Myoung Yang, David A. Palma, Keith Kwan, Alexander V. Louie, Richard Malthaner, Dalilah Fortin, George B. Rodrigues, Brian P. Yaremko, Joanna Laba, Stewart Gaede, Andrew Warner, Richard Inculet, Ting-Yim Lee
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of response after SABR is difficult. This prospective study aimed to develop a p
Externí odkaz:
https://doaj.org/article/7b32d039de8f45dca1ee9f5f9c9e0da3
Autor:
Lucas C. Mendez, Andrew J. Arifin, Glenn S. Bauman, Vikram M. Velker, Belal Ahmad, Michael Lock, Varagur M. Venkatesan, Tracy L. Sexton, George B. Rodrigues, Jeff Chen, Bryan Schaly, Andrew Warner, David P. D’Souza
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There has been recent interest in the use of hypofractionated radiotherapy in
Externí odkaz:
https://doaj.org/article/6d6b6a2b960b4ad7aa9d7bca47397483
Autor:
Sondos Zayed, MD, X. Melody Qu, MD, Andrew Warner, MSc, Tina Wanting Zhang, MD, Joanna M. Laba, MD, George B. Rodrigues, MD, PhD, David A. Palma, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 325-332 (2020)
Purpose: We examined whether female authorship, traditionally underrepresented in the radiation oncology (RO) literature, has improved during the past decade, and whether the introduction of double-blind peer review (where reviewers are blinded to au
Externí odkaz:
https://doaj.org/article/5f6fc26abede4588ac04c3c435ccaf28
Autor:
David A. Palma, Hanbo Chen, Houda Bahig, Stewart Gaede, Stephen Harrow, Joanna M. Laba, X. Melody Qu, George B. Rodrigues, Brian P. Yaremko, Edward Yu, Alexander V. Louie, Inderdeep Dhaliwal, Christopher J. Ryerson
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-17 (2019)
Abstract Background Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with
Externí odkaz:
https://doaj.org/article/9e2d916f092b4b5eb2f0df255c4e4e56
Autor:
David A. Palma, Robert Olson, Stephen Harrow, Rohann J. M. Correa, Famke Schneiders, Cornelis J. A. Haasbeek, George B. Rodrigues, Michael Lock, Brian P. Yaremko, Glenn S. Bauman, Belal Ahmad, Devin Schellenberg, Mitchell Liu, Stewart Gaede, Joanna Laba, Liam Mulroy, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Andrew Warner, Ben J. Slotman, Tanja D. de Gruijl, Alison Allan, Suresh Senan
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose, hypofractionated radiotherapy, and achieves excellent rates of local cont
Externí odkaz:
https://doaj.org/article/311e255a7ed5440d80c65380d5f3034c
Autor:
Rohann J. M. Correa, Belal Ahmad, Andrew Warner, Craig Johnson, Mary J. MacKenzie, Stephen E. Pautler, Glenn S. Bauman, George B. Rodrigues, Alexander V. Louie
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background Cytoreductive nephrectomy is thought to improve survival in metastatic renal cell carcinoma (mRCC). As many patients are ineligible for major surgery, we hypothesized that SABR could be a safe alternative. Methods In this dose-esc
Externí odkaz:
https://doaj.org/article/b7d9191ea461454c99367dea7b44ab7b